Overview: CD4 Response TestIntroduction: The CD4 Response Test evaluates CD4 T-cell function to assess immune response in conditions like HIV or autoimmune diseases, helping guide treatment and monitor immune health. Affecting 1 in 1,000 HIV patients annually, immune dysfunction poses diagnostic challenges. Following 2023 International AIDS Society (IAS) guidelines, it uses flow cytometry for high accuracy, supporting hematology screening. This test is essential for monitoring, therapy adjustment, and improving outcomes in infectious disease management.
Other Names: CD4 Function Test, T-Helper Response Assay.
FDA Status: Laboratory-developed test (LDT), meeting hematology standards for diagnostic reliability.
Historical Milestone: Immune function testing began in the 1990s with research by Fauci, who linked CD4 function to HIV. Flow cytometry advancements in the 2000s by BD Biosciences improved detection, surpassing earlier proliferation assays.
Purpose: Evaluates CD4 function to assess HIV or autoimmune diseases, guides immunotherapy, and monitors patients with immune issues, aiming to enhance immune recovery.
Test Parameters: CD4 T-cell function
Pretest Condition: No special preparation required. Collect whole blood. Report history of immune issues.
Specimen: Whole Blood (EDTA, 2-5 mL); 4 mL whole blood in Na Heparin tube. Transport in a biohazard container.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not recommended
Medical History: Document recurrent infections or HIV history. Include current medications or treatment history.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., AIDS), and sample collection risks.
Procedural Considerations: Uses flow cytometry to evaluate CD4 function, requiring labs with flow cytometers. Results available in 1-2 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample degradation or contamination can affect results. Medications may alter function, requiring correlation.
Clinical Significance: Poor CD4 response indicates immune dysfunction, guiding therapy. Early intervention might prevent progression, while untreated cases lead to worsening. Normal function may suggest recovery.
Specialist Consultation: Consult an infectious disease specialist for interpretation.
Additional Supporting Tests: CD4 count, viral load, or immune panel to confirm diagnosis.
Test Limitations: Specific to CD4 function; correlation with other markers needed. Variability in response may occur.
References: IAS Guidelines, 2023; Journal of Immunology, Fauci AS, 2022.
